Pyxis Oncology logo

Pyxis Oncology (PYXS) Q1 2025 Earnings

PYXS·Reported May 15, 2025·Before market open

Diluted EPS came in at $-0.35 (-483.3% YoY), missed the $-0.29 consensus by $0.06.

Diluted EPS
$-0.35missed by $0.06
Consensus: $-0.29
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2025

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about Pyxis Oncology's Q1 2025 earnings report.

Pyxis Oncology (PYXS) reported Q1 2025 earnings on May 15, 2025 before market open.

Pyxis Oncology reported diluted EPS of $-0.35 for Q1 2025.

EPS missed the consensus estimate of $-0.29 by $0.06.

Compared to the same quarter a year prior, diluted EPS declined 483.3% from $-0.06.

You can read the 10-Q periodic report (0000950170-25-071996) directly on SEC EDGAR. The filing index links above go to sec.gov.